NuVasive (NUVA) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to NuVasive (NUVA) Tops Q4 EPS by 2c
February 10, 2017 9:19 AM EST
UBS analyst Matt Miksic reiterates Buy rating and raises price target on NuVasive Inc. (NASDAQ: NUVA) to $82 (from $71), as the companys sales surpass pre-announcement, driven by a one-time order, while management makes progress on margins.
Miksic comments, "Management delivered upside to the company's... More
February 10, 2017 8:46 AM EST
Barclays raised its price target on NuVasive (NASDAQ: NUVA) to $80.00 (from $76.00) while maintaining a Overweight rating.
...
More
February 10, 2017 8:05 AM EST
Jefferies analyst Raj Denhoy reiterates Buy rating and raises price target on NuVasive Inc. (NASDAQ: NUVA) to $84 (from $79), as the company delivered unexpected upside with fourth quarter revenues above consensus, yet provided guidance that appears conservative.
Denhoy comments, "NUVA progresses down a... More
February 10, 2017 6:48 AM EST
Needham & Company analyst Mike Matson reiterates Hold rating on NuVasive Inc. (NASDAQ: NUVA), suggesting growth recovered in the fourth quarter of 2016 and now sees multiple levels for growth and margins in 2017.
Matson writes, "NUVA's 4Q16 revenue beat its 1/9/17 preannouncement and EPS beat consensus. And... More
